Veeva Systems Stock (NYSE:VEEV)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$204.53

52W Range

$162.72 - $236.90

50D Avg

$202.87

200D Avg

$203.16

Market Cap

$33.14B

Avg Vol (3M)

$891.35K

Beta

0.81

Div Yield

-

VEEV Company Profile


Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

7,172

IPO Date

Oct 16, 2013

Website

VEEV Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJan 24Jan 23Jan 22
Professional Services Veeva Research And Development$276.10M--
Subscription Services Veeva Research And Development$905.79M--
Technology Service$462.08M$422.06M$366.80M
Subscription and Circulation$1.90B$1.66B$1.51B
Professional Services Veeva Commercial Cloud$185.98M--
Subscription Services Veeva Commercial Cloud$995.80M--
Professional Services R&D Solutions-$244.87M$201.72M
Subscription Services R&D Solutions-$786.75M$607.52M
Subscription Services Commercial Solutions-$946.25M$876.46M
Professional Services Commercial Solutions-$177.19M$165.09M

Fiscal year ends in Jan 24 | Currency in USD

VEEV Financial Summary


Jan 24Jan 23Jan 22
Revenue$2.36B$2.16B$1.85B
Operating Income$429.33M$459.09M$505.50M
Net Income$525.71M$487.71M$427.39M
EBITDA$473.65M$488.21M$532.94M
Basic EPS$3.27$3.24$2.79
Diluted EPS$3.22$3.03$2.63

Fiscal year ends in Jan 24 | Currency in USD

Latest Earnings Call Transcripts


Q2 25Aug 28, 24 | 8:27 PM
Q1 25May 30, 24 | 9:08 PM
Q4 24Feb 29, 24 | 8:38 PM

Peer Comparison


TickerCompany
GEHCGE HealthCare Technologies Inc.
SDGRSchrödinger, Inc.
TXG10x Genomics, Inc.
ACCDAccolade, Inc.
PGNYProgyny, Inc.
GDRXGoodRx Holdings, Inc.
HQYHealthEquity, Inc.
DOCSDoximity, Inc.
CERTCertara, Inc.
TDOCTeladoc Health, Inc.
AMWLAmerican Well Corporation